Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-resistant strains. In this narrative review, through a fictional suggestive case of DS PTB, we guide the reader in a step-by-step commentary to provide an updated review of current evidence in the management of TB, from diagnosis to post-treatment follow-up. World Health Organization and Centre for Diseases Control (CDC) guidelines for TB, as well as the updated literature, were used to support this manuscript.
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians / Riccardi, Niccolò; Occhineri, Sara; Vanino, Elisa; Antonello, Roberta Maria; Pontarelli, Agostina; Saluzzo, Francesca; Masini, Tiziana; Besozzi, Giorgio; Tadolini, Marina; Codecasa, Luigi; null, null. - In: ANTIBIOTICS. - ISSN 2079-6382. - ELETTRONICO. - 12:12(2023), pp. 1733.1-1733.17. [10.3390/antibiotics12121733]
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians
Tadolini, Marina;
2023
Abstract
Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-resistant strains. In this narrative review, through a fictional suggestive case of DS PTB, we guide the reader in a step-by-step commentary to provide an updated review of current evidence in the management of TB, from diagnosis to post-treatment follow-up. World Health Organization and Centre for Diseases Control (CDC) guidelines for TB, as well as the updated literature, were used to support this manuscript.| File | Dimensione | Formato | |
|---|---|---|---|
|
antibiotics-12-01733.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
1.54 MB
Formato
Adobe PDF
|
1.54 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
